期刊文献+

低分割三维适形放疗结合化疗治疗非小细胞型肺癌疗效观察 被引量:6

Effect of 3-dimensional conformal hypofractionated high-dose radiotherapy combined with chemotherapy for non-small-cell lung cancer: a clinical observation
下载PDF
导出
摘要 目的探讨低分割三维适形放疗结合化疗治疗非小细胞型肺癌的疗效.方法采用低分割三维适形放疗治疗63例NSCLC患者,观察疗效、患者生存率及术后并发症.结果患者术后中位生存期14个月,肿瘤局部控制率79.1%,1、3、5年生存率分别是65.2%、23.2%、10.4%,3~4级放射性肺炎及食管炎的发生率分别为9.5%、4.8%.结论低分割三维适形放疗结合化疗治疗非小细胞肺癌有较好的疗效,局部复发仍然是治疗失败的主要原因之一. Objective To evaluate the clinical therapeutic effect of three-dimensional conformal hypofractionated high-dose radiotherapy combined with chemotherapy for non-small-cell lung cancer (NSCLC). Methods The combined treatment was carried out in 63 cases of NSCLC and the short-term effects, the patients' survival rate and complications were observed. Results Local control of tumor growth was achieved in 79.1% of the patients and the survival rates of 1, 3, and 5 years were 65.2%, 23.2%, and 10.4%, respectively. The median actual survival of the patients was 14 months. Late radiation pneumonitis (grade 3 or 4) and oesophagitis occurred in 9.5% and 4.8% of the patients, respectively. Conclusions Three-dimensional conformal hypofractionated high-dose radiotherapy combined with chemotherapy can be an effective and practical approach to treat NSCLC, but local recurrence remains the major factor of treatment failure.
出处 《第一军医大学学报》 CSCD 北大核心 2004年第11期1297-1298,共2页 Journal of First Military Medical University
关键词 低分割三维适形放疗 非小细胞型肺癌 化学治疗 照射剂量 lung neoplasms/radiotherapy radiotherapy, 3-dimensional conformal
  • 相关文献

参考文献5

  • 1张湘茹,孙燕,孔维红,周生余,冯奉仪.去甲长春花碱加顺铂治疗晚期非小细胞肺癌42例[J].中华肿瘤杂志,1998,20(1):60-62. 被引量:527
  • 2Greco C, Catalano G, Di Grazia A, et al. Radiotherapy of liver malignancies: From whole liver irradiation to stereotactic hypofractionated radiotherapy[J]. Tumori, 2004, 90(1): 73-9.
  • 3Lagerwaard FJ, Senan S, van Meerbeeck JP, et al. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control tor stageⅠ non-small cell lung cancer [J]? Radiother Oncol, 2002, 63 (2):151-7.
  • 4Choi N, Baumann M, Flentjie M, et al. Predictive factors in radiotherapy for non-small cell lung cancer: present status[J]. Lung Cancer,2001, 31(1): 43-56.
  • 5Mehta M, Scrimger R, Mackie R, et al. A new approach to dose escalation in non-small-cell cancer [J]. Iht J Radiat Oncol Biol Phys,2001, 49: 23-33.

二级参考文献2

  • 1管忠震,癌症,1993年,12卷,217页
  • 2张湘茹,北京医学,1992年,14卷,171页

共引文献526

同被引文献25

  • 1魏友英,贺小俊.沐舒坦防治放射性肺损伤的临床观察[J].癌症进展,2005,3(6). 被引量:4
  • 2翁毅敏,吴一龙,谷力加,冯卫能,程超,钟文昭,黄邵洪.可手术非小细胞肺癌淋巴结转移情况的分析[J].中国现代医学杂志,2005,15(3):412-414. 被引量:6
  • 3王希成,王思阳,杨曙,丁颖,商谊.后程三维适形放疗治疗Ⅲ期非小细胞肺癌临床研究[J].第一军医大学学报,2005,25(6):726-728. 被引量:7
  • 4傅小龙.放疗在非小细胞肺癌治疗中地位和研究进展[J].中国癌症杂志,2005,15(3):217-223. 被引量:30
  • 5van-Meerbeeck JP,Kramer GW,Van-Schil PE,et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer [J]. J Natl Cancer Inst,2007,99(6) :442-450.
  • 6Sause W,Kolesar P,Taylor S IV,et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer:Radi- ation Therapy Oncology Group,Eastern Cooperative Oncology Group, and Southwest Oncolozv Groun[ll. Chest. 2000_ 11 ? (24). ~5~-~6i4.
  • 7Friedel G,Budach W,Dippon J. Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection:a single-center study[J]. J Clin Oncol,2010,28(6):942-948.
  • 8Wang L,Correa CR,Zhao L,et al. The effect of radiation dose and chemotherapy on overall survival in 237 patients with Stage III non-small-cell lung cancer[J]. Int J Radiat Oncol Biol Phys,2009,73 (5) : 1383-1390.
  • 9Furuse K,Fukuoka F,Kawahara M,et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin,vindesine,and cisplatin in unresectable non-small-cell lung cancer[J]. Clin Oncol 1999,17(35) :2692 - 2699.
  • 10Socinski MA,Scappaticci FA,Samant M,et al. Safety and efficacy of combining sunitinib with bevacizumab+paclitaxel/carboplatin in non-small cell lung cancer[J]. J Thorac Oncol,2010,5(3):354-360.

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部